- Home
- ATRO vs COLL Comparison
ATRO vs COLL Comparison
Compare ATRO & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRO
- COLL
- Stock Information
- Founded
- ATRO 1968
- COLL 2002
- Country
- ATRO United States
- COLL United States
- Employees
- ATRO N/A
- COLL N/A
- Industry
- ATRO Military/Government/Technical
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- ATRO Industrials
- COLL Health Care
- Exchange
- ATRO Nasdaq
- COLL Nasdaq
- Market Cap
- ATRO 864.1M
- COLL 910.2M
- IPO Year
- ATRO N/A
- COLL 2015
- Fundamental
- Price
- ATRO $24.73
- COLL $29.39
- Analyst Decision
- ATRO Hold
- COLL Strong Buy
- Analyst Count
- ATRO 1
- COLL 5
- Target Price
- ATRO $23.00
- COLL $43.60
- AVG Volume (30 Days)
- ATRO 768.0K
- COLL 443.7K
- Earning Date
- ATRO 03-04-2025
- COLL 05-08-2025
- Dividend Yield
- ATRO N/A
- COLL N/A
- EPS Growth
- ATRO N/A
- COLL 43.56
- EPS
- ATRO N/A
- COLL 1.86
- Revenue
- ATRO $795,426,000.00
- COLL $631,449,000.00
- Revenue This Year
- ATRO $7.40
- COLL $20.00
- Revenue Next Year
- ATRO $5.77
- COLL $3.93
- P/E Ratio
- ATRO N/A
- COLL $15.65
- Revenue Growth
- ATRO 15.41
- COLL 11.41
- 52 Week Low
- ATRO $14.13
- COLL $27.28
- 52 Week High
- ATRO $26.63
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- ATRO 59.26
- COLL 45.81
- Support Level
- ATRO $23.54
- COLL $29.33
- Resistance Level
- ATRO $26.63
- COLL $30.84
- Average True Range (ATR)
- ATRO 0.77
- COLL 0.90
- MACD
- ATRO -0.30
- COLL 0.03
- Stochastic Oscillator
- ATRO 38.51
- COLL 35.98
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.